Prot #VT1021-01: A Phase 1 Study Evaluating the Safety, Pharmacology, and Preliminary Activity of VT1021 in Patients with Advanced Solid Tumors

Project: Research project

Project Details

StatusActive
Effective start/end date7/17/18 → 7/17/21

Funding

  • Syneos Health, Inc. (Prot #VT1021-01)
  • Vigeo Therapeutics, Incorporated (Prot #VT1021-01)
View all
View less